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surveillance of antimicrobial drug 
susceptibility patterns of V. cholerae. 
Providing early information on 
antimicrobial drug susceptibility to 
practitioners in affected areas will 
lessen the illness and death from this 
devastating disease. 
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Neisseria 
meningitidis Strain 
of Unknown 
Serogroup, China 
To the Editor:  Neisseria 
meningitidis is a major public health 
hazard in many parts of the world. 
This organism is classiﬁ   ed into 13 
serogroups, and most meningococcal 
disease is caused by strains that 
express 1 of the 5 types of capsular 
polysaccharides (A, B, C, Y, and 
W135). In the natural reservoir of 
the human nasopharynx, strains of N. 
meningitidis that do not ﬁ  t into 1 of 
the 13 serogroups and are presumably 
unencapsulated are common. By 
contrast, rare meningococcal diseases 
are caused by these nonserogroupable 
strains. In this article, we describe 
a case of N. meningitidis infection 
caused by a nonserogroupable strain 
in the People’s Republic of China and 
the genotype characteristics of this 
strain.
The patient was a 6-month-old 
boy who was admitted to a local 
hospital in Beijing in May 2009. The 
infection started suddenly with high 
fever (39°C). N. meningitidis infection 
was conﬁ   rmed on the basis of the 
clinical signs and results of laboratory 
examination. Nausea, vomiting, and 
neck stiffness developed, and the 
patient lost consciousness. Physical 
examination showed a positive Kernig 
sign and negative Brudzinski sign. 
The patient’s cerebrospinal ﬂ  uid 
sample was injected into chocolate 
agar, in which microbial growth was 
observed after 24 hours. The API NH 
system (bioMérieux, Marcy-Etoile, 
France) showed that the isolate was 
N. meningitidis. However, this strain 
could not be placed in a serogroup, 
even after speciﬁ  c antiserum (Remel, 
Lenexa, KS, USA) was used. No other 
disease with complement deﬁ  ciency 
was detected in the patient. The 
patient’s infection was treated with 
antimicrobial drugs, and he recovered 
completely.
We investigated this nonsero-
groupable  N. meningitidis strain by 
multilocus sequence typing (MLST), 
pulsed-ﬁ   eld gel electrophoresis 
(PFGE), and subtyping of the variable 
regions of the genes (porA, porB, and 
fetA) encoding the outer membrane 
proteins. MLST indicated that the 
fumC was a new allele with a new 
number 482. The allele numbers for 
abcZ,  adk, fumC,  gdh, pdhC, and 
pgm were 222, 3, 58, 386, 18, and 77, 
respectively. This strain was assigned 
a new sequence type number, ST7962.
Among the 44 complexes 
designed in the MLST database, 
ST7962 was most similar to the 
ST4821 complex with 3 identical 
loci. The PFGE pattern of this 
strain was compared with the PFGE 
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patterns in the reference database 
of  N. meningitidis from China by 
using BioNumerics version 5.10 
software (Applied Maths, Kortrijk, 
Belgium). At the time of comparison, 
the database contained 618 isolates 
of  N. meningitidis and 243 PFGE 
patterns. This strain had a single 
pattern that was clustered together 
with the ST4821 complex strains in 
the cluster tree based on the PFGE 
patterns. The PorA genotype of the 
strain was determined to be P1.7–2, 
14, which was a genotype associated 
with the ST4821 complex serogroup C 
strains that caused outbreaks in China 
in 2003 (1). The porB and fetA alleles 
of this strain were 3–18 and F4–21, 
respectively.
The genetic basis for the reason 
that this strain was nonserogroupable 
was studied by PCR and sequencing. 
PCR showed that this strain had intact 
capsule genetic islands of ctrA-D, 
synA-C, lipA, and lipB, and contained 
synD, encoding the serogroup B 
polysialyltransferase. The capsular 
gene clusters were sequenced entirely, 
and a missense mutation within 
synD was identiﬁ  ed  (Figure).  The 
mechanism underlying the capsule 
phase variation of N. meningitidis 
serogroup B involves a variation 
caused by slipped-strand mispairing 
in the polyC tract at the 5′ end of synD 
(2–4). A tract of 7 C residues encodes 
capsular expression, and an insertion 
or deletion of 1 C results in a missense 
mutation within synD, thereby leading 
to nonexpression of the capsule. 
Nucleotide sequencing of synD of 
our isolate revealed an insertion of 
1 C within the polyC tract. Thus, 
slipped-strand mispairing within synD 
was predicted to be the mechanism 
underlying the nonserogroupability of 
this strain.
Few reports have described 
invasive meningococcal disease 
caused by nons    erogroupable N. 
meningitidis strains; the lack of such 
reports suggests that complement 
deﬁ   ciency might be a predisposing 
factor, and all the reported isolates 
were determined to be capsule null 
locus (cnl) strains, which lacked the 
genetic islands encoding the entire 
capsule (5–7). However, the patient 
described here was not found to have 
a complement deﬁ   ciency, and the 
disease-associated nonserogroupable 
N. meningitidis strain in this study 
contained the genetic locus of an 
intact capsule.
In China, meningococcal poly-
saccharide vaccines A and C have 
been used for routine immunization. 
In many countries in Africa, repeated 
vaccination against N. meningitidis 
serogroups A and C have likely led to 
a selective increase in the incidence 
of meningococci of other serogroups, 
thereby resulting in a changed 
proﬁ   le of meningococcal disease 
(8). In recent years, invasive disease 
caused by N. meningitidis serogroup 
W135 and serogroup X strains has 
emerged in China (9,10). Therefore, 
meningococcal disease caused by 
serogroups other than A and C as well 
as nonserogroupable N. meningitidis 
strains appears to be an emerging 
problem and should be investigated 
epidemiologically.
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Figure. Genetic basis for the Neisseria meningitidis strain that cannot be placed in a known 
serogroup. A predicted slipped-strand mispairing occurred within synD, which encodes 
the serogroup B sialyltransferase. In wild-type N. meningitidis serogroup B (MC58), the 
synD polyC tract contains 7 C residues, and capsule is expressed. When an insertion 
(as in isolate 100924) of 1 C residue occurs, a result of local denaturation and mispairing 
followed by replication or repair, a premature stop codon is generated, and the capsule is 
not expressed.LETTERS
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etymologia etymologia
Pseudoterranova azarasi 
[sü-dō-′ter-ə-nō-və a-zär-a-sē]
From the Greek for false, Latin for earth and new, and Japanese for sea lion. First identiﬁ  ed in 1878 as a parasite 
in pinnipeds by Danish scientist Harald Krabbe, who suggested the name Ascaris decipiens, the taxonomic 
designation for these nematodes changed as knowledge of the life cycles and morphologic features of members of 
the order Ascaridida expanded.  In 1998, molecular examination found Pseudoterranova decipiens, long thought 
to be a monotype, consisted of genetically distinct sibling species. Mattiucci et al. proposed Pseudoterranova 
azarasi for 1 of the 5 sibling species, incorporating part of the name Porrocaecum azarasi, previously considered 
a synonym for Pseudoterranova decipiens.
Sources:  Berland B. Anisakis spp. In: Akuffo H, Linder E, Ljungström I, Wahlgren M, editors. Parasites of the colder climates. 
London: Taylor & Francis; 2003. p. 160–8; Krabbe H. On the ascarides of the seals and toothed whales. Annals and Magazine 
of Natural History. 1878; 5-S, 2(11):430–2; Mattiucci S, Paggi L, Nascetti G, Ishikura H, Kikuchi K, Sato N, et al. Allozyme and 
morphological identiﬁ  cation of Anisakis, Contracaecum and Pseudoterranova from Japanese waters (Nematoda, Ascaridoidea). 
Syst Parasitol. 1998;40:81–92. DOI: 10.1023/A:1005914926720 